InvestorsHub Logo
Followers 4
Posts 1483
Boards Moderated 0
Alias Born 12/11/2013

Re: None

Tuesday, 04/17/2018 10:27:44 AM

Tuesday, April 17, 2018 10:27:44 AM

Post# of 38634
Wim, they stated that almost all of the revenue came from PAR licensing !!

Seroquel = close to zero.


Keppra and Gluco shelved, and this idiots make a new offering instead of moving their NDA forward ?


Reading the management report it is now clear to everybody why I repeatedly wrote on this board TIME is MONEY. Each quarter makes a generic drammactically less valuable than the previous quarter.

Same for NDAs...collecting dust it is usually a demential strategy.


Let's now be realistic...the market will now start to price the new inevitable offering, the one which will trigger the funds overtaking control and then passing it up to a pharma taking over.

Odidi...shame on you !!